The new law on geographical indications and designations of
origin entered into force in Kosovo on January 27, 2016.
The aim of the new law is to further harmonize Kosovo's
legislation with the EU and bring it in line with Regulation (EU)
No. 1151/2012 of the European Parliament and of the Council of 21
November 2012 on quality schemes for agricultural products and
foodstuffs and Directive 2004/48/EC of the European Parliament and
of the Council of 29 April 2004 on the enforcement of intellectual
The new law more precisely defines identical designations of
origin or geographical indications, i.e. homonyms.
Provisions on trans-border geographical indications have been
added. Several groups may submit a joint application in the case of
a name designating a trans-border geographical area or a
traditional name connected to a trans-border geographical area.
Provisions on cancellation have been amended. Under the new law,
the decision on a protected designation of origin or a protected
geographical indication may be cancelled if no product is placed on
the market for at least seven years.
Provisions on protection of traditional specialties have been
introduced, explaining the criteria, product specifications and the
registration procedure in general.
The applicable bylaw is still the Administrative Instruction No.
05/2014, which provides detailed information on the procedures
prescribed by the law, namely the procedures of application,
registration, publication, recordal of changes, renewal,
termination of validity, etc.
1.The trade mark shall not entitle the proprietor to prohibit its use in relation to goods which have been put on the market in the Community under that trade mark by the proprietor or with his consent.
The UK government has not yet invoked Article 50 of the Treaty on European Union (this is likely to happen by the end of March), and the UK's actual exit from the European Union is at least two years away.
Without doubt Malta offers significant opportunities for the generics drugs Industry and the
evidence for this lies in the pharmaceutical patenting history of the country and in its legislative
In a landmark judgment, the High Court has granted a novel type of declaratory relief to clear the route to market for a product facing a raft of pending patent applications...
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).